ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,351Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 917

$534K Total Retail Price of All Prescriptions

Rank: 100 out of 917

476 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 9,111 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 467 442 1 3
SIMVASTATIN 409 354 2 2
HYDROCODONE-ACETAMINOPHEN 389 253 S3 3 6
LISINOPRIL 346 291 4 1
CITALOPRAM HBR 343 322 5 15
HYDROCHLOROTHIAZIDE 328 284 6 9
FUROSEMIDE 312 289 7 7
OMEPRAZOLE 305 267 8 4
ATORVASTATIN CALCIUM 274 256 9 14
AMLODIPINE BESYLATE 274 260 9 5
POTASSIUM CHLORIDE 255 244 11 16
LOSARTAN POTASSIUM 208 194 12 13
GABAPENTIN 189 141 13 17
METOPROLOL SUCCINATE 185 157 14 18
METFORMIN HCL 184 161 15 8
ZOLPIDEM TARTRATE 182 160 16 21
AMITRIPTYLINE HCL 149 97 R 17 67
WARFARIN SODIUM 142 133 18 10
METOPROLOL TARTRATE 142 118 18 11
MIRTAZAPINE 128 104 20 39
ALENDRONATE SODIUM 107 102 21 23
TAMSULOSIN HCL 99 85 22 25
RANITIDINE HCL 97 54 23 29
LOSARTAN-HYDROCHLOROTHIAZIDE 96 92 24 62
FLUOXETINE HCL 95 71 25 38
DONEPEZIL HCL 95 95 25 32
ESTRADIOL 93 66 R 27 102
SERTRALINE HCL 91 83 28 24
ZETIA 82 60 29 93
GEMFIBROZIL 82 63 29 140
VENLAFAXINE HCL ER 75 58 31 78
PREDNISONE 75 44 31 34
BUPROPION HCL SR 74 47 33 101
METHOCARBAMOL 72 37 R 34 87
ALLOPURINOL 72 50 34 31
METHADONE HCL 71 18 S2 36 59
BUPROPION XL 71 45 36 230
SYNTHROID 70 70 38 68
LOVASTATIN 70 64 38 19
FENTANYL 69 62 S2 40 58
CARVEDILOL 67 42 41 33
KLOR-CON 10 66 64 42 115
PRAVASTATIN SODIUM 66 63 42 20
ATENOLOL 62 46 44 12
ESCITALOPRAM OXALATE 60 41 45 114
TRIAMCINOLONE ACETONIDE 60 41 45 96
NAMENDA 59 59 47 43
TRAMADOL HCL 58 42 48 28
PANTOPRAZOLE SODIUM 57 30 49 44
VYTORIN 53 45 50 214
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 51 51 42
FLUTICASONE PROPIONATE 52 48 51 26
CIPROFLOXACIN HCL 52 49 51 72
CYMBALTA 52 31 51 56
SPIRONOLACTONE 51 29 55 55
SUCRALFATE 51 35 55 211
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.